Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial

Fig. 3

Change from baseline in a DAS28-CRP, b DAS28-ESR, c SDAI, and d CDAI scores over time. CDAI, Clinical Disease Activity Index; CRP, c-reactive protein; DAS28, Disease Activity Score in 28 joints; ESR, erythrocyte sedimentation rate; SDAI, Simplified Disease Activity Index

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us